Galderma announced that it has received approval from Health Canada for Restylane Shaype, a hyaluronic acid (HA) injectable designed for temporary augmentation of the chin region. It is engineered to build and shape on bone with deep injection for a bone-mimicking effect.

The chin is a critical component of overall appearance that influences the balance of facial proportions, profile and shape. Genetics and age can impact overall chin definition, which may cause the appearance of a double chin. For decades, there has been a heavy reliance on implants to create structure in the lower face, with no non-surgical options available offering qualities close to an implant, per Galderma.

Read more at MedEsthetics >>